Professional development Vacancies

Tarceva (erlotinib)

29.07.2013 Updated 22.10.2019 9349 views

By MoH of Ukraine order No. 574 of 05.07.13, the package leaflet (hereinafter – the leaflet) of the original (reference) medicinal product containing erlotinib, namely Tarceva, tablets, was approved with amendments and additions to the following leaflet sections: "Indications", "Method of administration", "Adverse reactions", "Use during pregnancy or breastfeeding", "Children", "Special warnings and precautions for use", "Interaction with other medicinal products and other forms of interaction".

List of medicinal products containing erlotinib as an active ingredient, authorized for medical use in Ukraine.